ResQ Pharma, Inc
ResQ Pharma, Inc
  • Home
  • About Us
  • Background
  • Target Indications
  • History
  • Contact
  • More
    • Home
    • About Us
    • Background
    • Target Indications
    • History
    • Contact
  • Home
  • About Us
  • Background
  • Target Indications
  • History
  • Contact

Meet the Team

Guy Weinberg, MD

Christopher Bryant, PhD

Mukesh Kumar, PhD, RAC

Founder and President

Dr. Weinberg is a Founder of ResQ Pharma and the inventor of LRT. He is currently a Professor of Anesthesiology at the

University of Illinois College of Medicine

at Chicago.  He has authored over

100 peer-reviewed research articles. 

Mukesh Kumar, PhD, RAC

Christopher Bryant, PhD

Mukesh Kumar, PhD, RAC

Director of Regulatory Affairs

Dr. Mukesh Kumar is CEO and Founder of FDAMap, a Washington DC-based firm helping manufacturers and developers of FDA-regulated products in regulatory affairs, quality assurance, clinical trials, and development strategies. He has led the clinical development of more than 100 products and 100 GCP, GLP, GMP, a

Director of Regulatory Affairs

Dr. Mukesh Kumar is CEO and Founder of FDAMap, a Washington DC-based firm helping manufacturers and developers of FDA-regulated products in regulatory affairs, quality assurance, clinical trials, and development strategies. He has led the clinical development of more than 100 products and 100 GCP, GLP, GMP, and GACP audits in the North and South Americas, Europe, and Asia.

Christopher Bryant, PhD

Christopher Bryant, PhD

Christopher Bryant, PhD

Director of Product Development

Dr. Bryant brings more than 25 years in R&D management. He is the Founder of Sagitta Biotherapeutics and Vice President of Technical Operations at Levo Therapeutics.

He is a specialist in all phases of

biologics development. 

Rick Hubbard, MD

Rick Hubbard, MD

Christopher Bryant, PhD

Clinical Affairs

Dr. Hubbard is the former Vice President of Clinical Research at Pfizer and member of FDA’s Pulmonary and Allergy Advisory Committee. He is on the Board of Northwestern University’s Biomedical IRB.  

Jamie Schupp, JD

Rick Hubbard, MD

Jamie Schupp, JD

Chief Administrative Officer

and General Counsel

Mr. Schupp is an accomplished attorney with extensive experience as outside counsel, in-house counsel and senior business management, leading efforts to transform business practices to improve process efficiency, strengthen operations and drive business production. 

Dominic O’Keefe

Rick Hubbard, MD

Jamie Schupp, JD

Chief Operating Officer

Owner at Physician First Consultants, LLC with over 14 years of successful sales and business/product development experience.

Board of Directors
Advisory Board

  

LipidRescue® is an investigational drug; the safety and efficacy of the drug have not been approved or authorized by FDA. 

LipidRescue® is a proposed proprietary name that is subject to FDA approval. 


Website designed by JDW

Copyright © 2021 ResQ Pharma, Inc - All Rights Reserved.


Powered by GoDaddy